Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP574276.RAw0NgtNrwrSZxpcWtq3bugLekTdq6qJWePcpewj3yV1g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP574276.RAw0NgtNrwrSZxpcWtq3bugLekTdq6qJWePcpewj3yV1g130_assertion type Assertion NP574276.RAw0NgtNrwrSZxpcWtq3bugLekTdq6qJWePcpewj3yV1g130_head.
- NP574276.RAw0NgtNrwrSZxpcWtq3bugLekTdq6qJWePcpewj3yV1g130_assertion description "[Although there was no difference in recurrence-free survival between patients with CD133 overexpression and without, the patients with CD133 overexpression had significantly poorer overall survival (P = 0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP574276.RAw0NgtNrwrSZxpcWtq3bugLekTdq6qJWePcpewj3yV1g130_provenance.
- NP574276.RAw0NgtNrwrSZxpcWtq3bugLekTdq6qJWePcpewj3yV1g130_assertion evidence source_evidence_literature NP574276.RAw0NgtNrwrSZxpcWtq3bugLekTdq6qJWePcpewj3yV1g130_provenance.
- NP574276.RAw0NgtNrwrSZxpcWtq3bugLekTdq6qJWePcpewj3yV1g130_assertion SIO_000772 18754869 NP574276.RAw0NgtNrwrSZxpcWtq3bugLekTdq6qJWePcpewj3yV1g130_provenance.
- NP574276.RAw0NgtNrwrSZxpcWtq3bugLekTdq6qJWePcpewj3yV1g130_assertion wasDerivedFrom befree-20140225 NP574276.RAw0NgtNrwrSZxpcWtq3bugLekTdq6qJWePcpewj3yV1g130_provenance.
- NP574276.RAw0NgtNrwrSZxpcWtq3bugLekTdq6qJWePcpewj3yV1g130_assertion wasGeneratedBy ECO_0000203 NP574276.RAw0NgtNrwrSZxpcWtq3bugLekTdq6qJWePcpewj3yV1g130_provenance.